Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 936.00
+1.05 (0.11%)
Dec 4, 2025, 3:30 PM IST
Zydus Lifesciences Employees
Zydus Lifesciences had 27,917 employees as of March 31, 2025. The number of employees increased by 996 or 3.70% compared to the previous year.
Employees
27,917
Change (1Y)
996
Growth (1Y)
3.70%
Revenue / Employee
8.77M INR
Profits / Employee
1.76M INR
Market Cap
940.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,917 | 996 | 3.70% |
| Mar 31, 2024 | 26,921 | 3,895 | 16.92% |
| Mar 31, 2023 | 23,026 | -717 | -3.02% |
| Mar 31, 2022 | 23,743 | -669 | -2.74% |
| Mar 31, 2021 | 24,412 | -588 | -2.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Biocon | 16,315 |
| Glenmark Pharmaceuticals | 15,800 |
Zydus Lifesciences News
- 4 hours ago - Zydus Lifesciences receives EIR from USFDA for the injectable facility at Jarod - Business Upturn
- 6 days ago - Top stocks to watch today, November 28: Adani Enterprises, Wipro, TCS, Tata Technologies, Zydus Lifesciences and more - Business Upturn
- 7 days ago - Zydus Lifesciences gets USFDA Tentative nod for Empagliflozin and Linagliptin tablets - Business Upturn
- 8 days ago - Zydus Lifesciences signs exclusive licensing agreement with RK Pharma for novel oncology supportive care injectable - Business Upturn
- 8 days ago - Top stocks to watch today, November 26: NCC, Zydus Lifesciences, UBL, Waaree Energies, NELCO and more - Business Upturn
- 8 days ago - Top stocks to watch on November 26, 2025: NCC, Zen Technologies, Zydus Lifesciences, Bharti Airtel, HCL Tech, ACS Technologies in focus today - Business Upturn
- 20 days ago - Zydus Lifesciences secures USFDA approval for Leuprolide Acetate Injection - Business Upturn
- 21 days ago - Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate capsule, 231 mg - Business Upturn